Eurofins Scientific SE
ENXTPA-ERF
Company Overview
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Name
Eurofins Scientific SE
CEO
Dr. Gilles G. Martin Ph.D.
Website
www.eurofins.com
Sector
Life Sciences Tools and Services
Year Founded
1987
Profile
Market Cap
€10.02B
EV
€12.93B
Shares Out
191.37M
Revenue
€6,723.8M
Employees
61,798
Margins
Gross
22.19%
EBITDA
19.45%
Operating
12.2%
Pre-Tax
7.5%
Net
5.64%
FCF
11.12%
Returns (5Yr Avg)
ROA
5.47%
ROTA
15.51%
ROE
12.06%
ROCE
12.05%
ROIC
8.57%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
€60.34
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
€681.2M
Net Debt
€2,862.9M
Debt/Equity
0.67
EBIT/Interest
5.8
Growth (CAGR)
Rev 3Yr
1.72%
Rev 5Yr
9.84%
Rev 10Yr
17.87%
Dil EPS 3Yr
-26%
Dil EPS 5Yr
16.35%
Dil EPS 10Yr
16.8%
Rev Fwd 2Yr
7.76%
EBITDA Fwd 2Yr
11.33%
EPS Fwd 2Yr
13.13%
EPS LT Growth Est
12.15%
Dividends
Yield
—
Payout
29.6%
DPS
€0.5
DPS Growth 3Yr
-9.74%
DPS Growth 5Yr
11.66%
DPS Growth 10Yr
15.34%
DPS Growth Fwd 2Yr
22.34%